Second International Workshop on Myeloma: advances in biology and therapy of multiple myeloma
Barlogie, B.; Alexanian, R.
Cancer Research 49(24 Pt 1): 7172-7175
1989
ISSN/ISBN: 0008-5472 PMID: 2479477 Document Number: 336529
Document emailed within 1 workday
Related Documents
Klein, B.; Bataille, R. 1990: Advances in the biology of multiple myeloma Pathologie-Biologie 38(8): 820-821Kosaka, M. 1996: Advances in the pathogenesis, biology, and management of multiple myeloma Rinsho Byori. Japanese Journal of Clinical Pathology 44(8): 743-749
Weber, D.M. 2003: Strategies in treating newly diagnosed or untreated multiple myeloma patients. from the Multiple Myeloma Research Foundation Oncology 17(6): 765-767
Van Camp, B.; Van Riet, I. 1998: Homing mechanisms in the biology of multiple myeloma Verhandelingen - Koninklijke Academie Voor Geneeskunde van Belgie 60(3): 163-194
Bataille, R. 1997: New insights in the clinical biology of multiple myeloma Seminars in Hematology 34(1 Suppl 1: 23-28
Kurtin, S. 2011: Advances and new challenges in multiple myeloma Oncology 25(4 Suppl Nurse Ed): 33-34
Varterasian, M.L. 1995: Biologic and clinical advances in multiple myeloma Oncology 9(5): 417
Miwa, A. 2007: Advances in therapeutic strategies for multiple myeloma Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(13): 2200-2216
Pasqualetti, P.; Casale, R.; Collacciani, A.; Colantonio, D. 1989: Evaluation of a morphologic staging method (myeloma progression score) in multiple myeloma Medicina 9(3): 280-282
Wu, M-Jei.; Fang, H-Chang.; Chang, T-Yuan.; Lo, Y-Shing.; Chung, H-Min. 2002: Multiple myeloma with myeloma nephropathy in a patient with Hashimoto's thyroiditis Journal of the Formosan Medical Association 101(6): 421-424
Stevenson, F.; Anderson, K.C. 1999: Introduction: immunotherapy for multiple myeloma--insights and advances Seminars in Hematology 36(1 Suppl. 3): 1-2
Facon, T. 2006: Advances in the treatment of elderly patients with multiple myeloma Clinical Advances in Hematology and Oncology: H&o 4(7): 501-502
Jackson, N.; Ling, N.R.; Ball, J.; Bromidge, E.; Nathan, P.D.; Franklin, I.M. 1988: An analysis of myeloma plasma cell phenotype using antibodies defined at the IIIrd International Workshop on Human Leucocyte Differentiation Antigens Clinical and Experimental Immunology 72(3): 351-356
García Laraña, J.; Díaz Mediavilla, J.; Martínez, R.; Lahuerta, J.J.; Alegre, A.; Odriozola, J.; Sureda, A.; San Miguel, J.; De la Rubia, J.; Escudero, A.; Conde, E.; Bladé, J.; Cabrera, R.; Gastearena, J.; Besalduch, J.; Vidal, M.J.; Hernández, F.; Rifon, J.; Leon, A.; Mataix, R.; Parody, R.; Moraleda, J.M.; Solano, C.; de Pablos, J.M.; Sánchez, J.J. 1997: Maintenance treatment with interferon-alfa in multiple myeloma after autotransplantation of peripheral blood progenitor cells. Spanish Register of Transplantation in Myeloma Sangre 42(Suppl 1): 38-41
Reiman, T.; Keats, J. 2001: VIII International Myeloma Workshop, Banff Springs Hotel, Banff, Alberta, Canada, 4-8 May 2001 European Journal of Haematology 67(3): 199-202
Teunissen, L.L.; Notermans, N.C. 1998: The risk of Kahler disease (multiple myeloma) in patients with a paraproteinemia: myeloma risk score, developed in the region of the Integral Cancer Center, West Nederlands Tijdschrift Voor Geneeskunde 142(43): 2374-2375
Takahashi, T.; Makiguchi, Y.; Hinoda, Y.; Kakiuchi, H.; Nakagawa, N.; Imai, K.; Yachi, A. 1994: Expression of MUC1 on myeloma cells and induction of HLA-unrestricted CTL against MUC1 from a multiple myeloma patient Journal of Immunology 153(5): 2102-2109
Avvisati, G.; Pulsoni, A.; Petrucci, M.T.; Tribalto, M. 1990: Therapy of multiple myeloma and its complications Recenti Progressi in Medicina 81(10): 642-650
Izumi, T. 2014: Novel targeted therapy in multiple myeloma Nihon Rinsho. Japanese Journal of Clinical Medicine 72(6): 1089-1093
Gisslinger, H. 1997: Interferon alpha in the therapy of multiple myeloma Leukemia 11(Suppl 5): S52-S56